Earth Life Sciences Inc.

CLTSOTCTechnology● Active

$0.00

+$0.00(+0.00%)

Market Cap$99989

P/E Ratio—

52W High$0.0001

52W Low$0.000001

Avg Volume18K

Open$0.00

Beta-55.88

Overview

Earth Life Sciences Inc. (CLTS) Revenue

Annual & quarterly revenue history · segment & region breakdown

CLTS · revenue · updated Jun 9, 2026

Core revenue metrics

Trailing 12 months

Earth Life Sciences Inc. trailing twelve-month (TTM) revenue is $0.00B, an increase of 0.00% year-over-year from $0.00B in FY2021.

TTM revenue

$0.00B

4-quarter sum · USD

YoY growth

+0.00%

vs FY2021 $0.00B

Price / sales

—

mktCap ÷ TTM rev

Revenue per day

—

Est. TTM ÷ 365

Revenue / employee

$0K

1 employees

FY2021

$0.00B

FY2020

$0.00B

5Y CAGR

—

Fiscal year end

Dec 31

Currency

USD · GAAP

Filing

10-K / 10-Q

Source: FMP · Earth Life Sciences Inc. SEC filings · GAAPUpdated: 2026-06-09

Revenue trend

2021 – 2002 · Annual

YoY revenue growth %

revenue trend · revenue chart · revenue by year · revenue history

Revenue history

Fiscal year end	Revenue	Change	Growth
2021-12-31	$0.00B	+$0.00B	—
2020-12-31	$0.00B	+$0.00B	—
2019-12-31	$0.00B	+$0.00B	—
2018-12-31	$0.00B	+$0.00B	—
2017-12-31	$0.00B	-$0.00B	-100.00%
2016-12-31	$0.00B	+$0.00B	+74.91%
2015-12-31	$0.00B	-$0.00B	-50.24%
2014-12-31	$0.00B	-$0.00B	-17.26%
2013-12-31	$0.00B	+$0.00B	+59.76%
2012-12-31	$0.00B	+$0.00B	+222.23%

CLTS revenue by year · CLTS revenue history · CLTS annual revenue data

About Revenue & Reporting

Revenue (also called sales, net sales, or turnover) is the total income Earth Life Sciences Inc. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.

Earth Life Sciences Inc. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.

Data sourced from Earth Life Sciences Inc.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.

Figures tie to SEC 10-K/10-Q and FMP income-statement endpoints where noted.

Price history Financial statements Forecast

Frequently asked questions

CLTS revenue · 4 questions

CLTS's trailing twelve-month (TTM) revenue is $0.00B. That is an increase of 0.00% year-over-year from $0.00B in FY2021.

CLTS revenueCLTS annual revenuewhat is CLTS revenueCLTS TTM revenue

▸ Source: FMP · Earth Life Sciences Inc. SEC filings · GAAP · Earth Life Sciences Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026